MCID: PRT018
MIFTS: 49

Portal Vein Thrombosis malady

Categories: Cardiovascular diseases, Liver diseases, Rare diseases, Gastrointestinal diseases, Blood diseases

Aliases & Classifications for Portal Vein Thrombosis

Aliases & Descriptions for Portal Vein Thrombosis:

Name: Portal Vein Thrombosis 12 56 29 52 14 69

Characteristics:

Orphanet epidemiological data:

56
portal vein thrombosis
Inheritance: Not applicable; Age of onset: All ages;

Classifications:

Orphanet: 56  
Rare hepatic diseases


External Ids:

Disease Ontology 12 DOID:11695
ICD10 33 I81
ICD9CM 35 452
NCIt 47 C78565
SNOMED-CT 64 155455003 17920008
Orphanet 56 ORPHA854
UMLS via Orphanet 70 C0155773
ICD10 via Orphanet 34 I81
UMLS 69 C0155773

Summaries for Portal Vein Thrombosis

Disease Ontology : 12 A vein disease that is characterized by a blood clot that forms within the hepatic portal vein.

MalaCards based summary : Portal Vein Thrombosis is related to myeloproliferative neoplasm and budd-chiari syndrome. An important gene associated with Portal Vein Thrombosis is F2 (Coagulation Factor II, Thrombin), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and Collagen chain trimerization. The drugs Oxaliplatin and Cisplatin have been mentioned in the context of this disorder. Affiliated tissues include liver, colon and myeloid, and related phenotypes are homeostasis/metabolism and integument

Wikipedia : 71 Portal vein thrombosis, previously known as Cauchois–Eppinger–Frugoni syndrome, is a form of venous... more...

Related Diseases for Portal Vein Thrombosis

Diseases related to Portal Vein Thrombosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 249)
id Related Disease Score Top Affiliating Genes
1 myeloproliferative neoplasm 29.7 F2 JAK2 SELP SERPINC1
2 budd-chiari syndrome 29.7 APOH F2 F5 MTHFR SELP SERPINC1
3 essential thrombocythemia 29.4 F2 F7 SERPINC1
4 obstructive jaundice 29.3 APOH F2 F5 MTHFR SERPINC1
5 myocardial infarction 28.7 F2 F5 F7 MTHFR SELP SERPINC1
6 thrombosis 11.1
7 hepatocellular carcinoma 10.6
8 hepatitis 10.5
9 liver cirrhosis 10.4
10 portal hypertension 10.3
11 pancreatitis 10.3
12 congenital insensitivity to pain with severe intellectual disability 10.3 F2 F5
13 multiple familial trichoepithelioma 10.3 F5 MTHFR
14 oxyphilic adenoma 10.3 F2 F5
15 scn8a-related epilepsy with encephalopathy 10.3 F2 MTHFR
16 miller-dieker lissencephaly syndrome 10.2 F2 SERPINC1
17 influenza 10.2 F2 SERPINC1
18 freiberg's disease 10.2 F2 SERPINC1
19 chorioretinal scar 10.2 F2 SERPINC1
20 mixed hepatoblastoma 10.2 F2 SERPINC1
21 med13l syndrome 10.2 APOH F5
22 peanut allergy 10.2 F2 SERPINC1
23 neutropenia 10.2 MTHFR SERPINE1
24 dmd-related dilated cardiomyopathy 10.2 F2 SERPINC1
25 achard thiers syndrome 10.2 APOH F5
26 schwannoma of jugular foramen 10.2 F2 SERPINC1
27 photosensitive epilepsy 10.2 F2 F5 MTHFR
28 landau-kleffner syndrome 10.2 APOH F2
29 brazilian hemorrhagic fever 10.2 SERPINC1 SERPINE1
30 houlston ironton temple syndrome 10.2 F2 F5 MTHFR
31 cerebellar astrocytoma 10.2 F2 SERPINC1
32 villous adenoma 10.2 F2 F5 MTHFR
33 prostatitis 10.2 APOH F2
34 social phobia 10.2 AFP F2
35 pancreatic ductal carcinoma 10.2 F2 F5 SERPINC1
36 rectum leiomyoma 10.2 AFP F2
37 inherited blood coagulation disease 10.2 F5 SERPINE1
38 childhood type dermatomyositis 10.2 F2 F5 MTHFR
39 eagle syndrome 10.1 F2 F5 SERPINC1
40 myosclerosis, congenital 10.1 F5 MTHFR SERPINC1
41 mixed epithelial tumor of ovary 10.1 F2 MTHFR SERPINC1
42 fallopian tube leiomyoma 10.1 AFP MTHFR
43 aids dementia complex 10.1 F2 F5 SERPINC1
44 prostatic hypertrophy 10.1 F2 SELP
45 absence of innominate vein 10.1 F5 MTHFR SERPINE1
46 aminoaciduria 10.1 F5 MTHFR SERPINE1
47 liver disease 10.1
48 ductal carcinoma in situ 10.1 F2 MTHFR SERPINC1
49 alpha-2-plasmin inhibitor deficiency 10.1 F2 MTHFR SERPINC1
50 secretory diarrhea myopathy and deafness 10.1 SERPINC1 SERPINE1

Comorbidity relations with Portal Vein Thrombosis via Phenotypic Disease Network (PDN):


Active Peptic Ulcer Disease Hepatic Encephalopathy
Mesenteric Artery Ischemia Portal Hypertension

Graphical network of the top 20 diseases related to Portal Vein Thrombosis:



Diseases related to Portal Vein Thrombosis

Symptoms & Phenotypes for Portal Vein Thrombosis

MGI Mouse Phenotypes related to Portal Vein Thrombosis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.96 F2 F5 F7 JAK2 MTHFR SELP
2 integument MP:0010771 9.63 F2 F5 JAK2 MTHFR SELP SERPINE1
3 liver/biliary system MP:0005370 9.43 F5 JAK2 SELP SERPINC1 SERPINE1 AFP
4 mortality/aging MP:0010768 9.32 APOH F2 F5 F7 JAK2 MTHFR

Drugs & Therapeutics for Portal Vein Thrombosis

Drugs for Portal Vein Thrombosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 130)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Oxaliplatin Approved, Investigational Phase 4,Phase 3,Phase 2 61825-94-3 5310940 9887054 6857599, 9887054 43805
2
Cisplatin Approved Phase 4,Phase 3,Phase 2 15663-27-1 84093 441203 2767
3
Ethiodized oil Approved Phase 4,Phase 3,Phase 2 8008-53-5
4
Benzocaine Approved Phase 4 1994-09-7, 94-09-7 2337
5
Warfarin Approved Phase 4,Phase 3,Phase 2 81-81-2 6691 54678486
6
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2 9005-49-6 772 46507594
7 Nadroparin Approved Phase 4 9041-08-1
8
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
9
Dalteparin Approved Phase 4,Phase 3,Phase 2 9041-08-1
10
Dipyridamole Approved Phase 4 58-32-2 3108
11
Desogestrel Approved Phase 4 54024-22-5 40973
12
Etonogestrel Approved, Investigational Phase 4 54048-10-1 40976 6917715
13
Glucosamine Approved, Nutraceutical Phase 4 3416-24-8 439213
14 tannic acid Approved, Nutraceutical Phase 4
15 Anesthetics Phase 4,Phase 2,Phase 1
16 Liver Extracts Phase 4,Phase 3,Phase 2,Phase 1
17
s 1 (combination) Phase 4
18 Pharmaceutical Solutions Phase 4,Phase 3
19 Antimetabolites Phase 4,Phase 3,Phase 2
20 Calcium, Dietary Phase 4,Phase 3
21 Vasodilator Agents Phase 4,Phase 3,Phase 2
22 Anticoagulants Phase 4,Phase 3,Phase 2
23 Fibrinolytic Agents Phase 4,Phase 3,Phase 2
24 Glucuronyl glucosamine glycan sulfate Phase 4
25 Hypoglycemic Agents Phase 4
26 Hypolipidemic Agents Phase 4,Phase 3
27 Lipid Regulating Agents Phase 4,Phase 3
28 calcium heparin Phase 4,Phase 3,Phase 2
29 Bone Density Conservation Agents Phase 4
30 Analgesics Phase 4
31 Analgesics, Non-Narcotic Phase 4
32 Anti-Inflammatory Agents Phase 4
33 Anti-Inflammatory Agents, Non-Steroidal Phase 4
34 Antipyretics Phase 4
35 Antirheumatic Agents Phase 4
36 Cyclooxygenase Inhibitors Phase 4
37 Heparin, Low-Molecular-Weight Phase 4,Phase 3,Phase 2
38 Peripheral Nervous System Agents Phase 4
39 Phosphodiesterase Inhibitors Phase 4
40 Platelet Aggregation Inhibitors Phase 4,Phase 2
41 Hormone Antagonists Phase 4,Phase 3
42 Hormones Phase 4,Phase 3
43 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3
44 Contraceptive Agents Phase 4
45 Contraceptives, Oral Phase 4
46
Ethylene Phase 4 74-85-1 6325
47 Progestins Phase 4
48
Norfloxacin Approved Phase 3 70458-96-7 4539
49
Propranolol Approved, Investigational Phase 3 525-66-6 4946
50
Ceftibuten Approved Phase 3 97519-39-6 5282241 5282242

Interventional clinical trials:

(show top 50) (show all 101)
id Name Status NCT ID Phase
1 Hepatic Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis Unknown status NCT01350206 Phase 4
2 A RCT of Oral S-1 in Combination With Sequential HAIC of Oxaliplatin After TACE in Patients With Advanced HCC Unknown status NCT01997957 Phase 4
3 Outcome of Transarterial Chemo-embolization (TACE) in Hepatocellular Carcinoma Patients With Partial Portal Vein Thrombosis Completed NCT03007212 Phase 4
4 A Clinical Trial of the Vessel Sealing System (LigaSure) in Azygoportal Disconnection and Splenectomy in Patients With Portal Hypertension Completed NCT00965744 Phase 4
5 Preoperative Transarterial Chemoembolization for Resectable HCC With Portal Venous Invasion Completed NCT01952353 Phase 4
6 Resection vs. Best Supportive Care for Hepatocellular Carcinoma (HCC) With Portal Venous Thrombus Completed NCT01600196 Phase 4
7 Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis Completed NCT00646100 Phase 4
8 The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis Recruiting NCT02398357 Phase 4
9 Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy Recruiting NCT02238444 Phase 4
10 Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection Recruiting NCT02247414 Phase 4
11 A Trial to Compare Surgery With Sorafenib for Hepatic Celluler Cancer With Portal Vein Tumor Thrombosis Recruiting NCT03178656 Phase 4
12 Contraception in Women With Sickle Cell Disease Active, not recruiting NCT02594462 Phase 4
13 The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis:A Multicenter RCT Not yet recruiting NCT02630095 Phase 4
14 ETOS: Minimal Hepatic Encephalopathy in Childhood and Young Adult: epidemiOlogical Study and Pilot Interventional Study Unknown status NCT01798329 Phase 3
15 Probiotics for Portal Hypertension Unknown status NCT01134692 Phase 3
16 A Prospective, Randomized Trial of Histoacryl Injection Versus Thrombin in the Control of Acute Gastric Variceal Bleeding Unknown status NCT01717612 Phase 3
17 Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis Completed NCT02250391 Phase 3
18 Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding Completed NCT01095185 Phase 3
19 Combination Treatment for Advanced Liver Cancer Completed NCT02149771 Phase 3
20 Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis. Recruiting NCT02555111 Phase 3
21 TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV Recruiting NCT02853526 Phase 3
22 Treatment of Splanchnic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study Recruiting NCT02627053 Phase 3
23 Multicenter Prospective Randomized Trial of the Effect of Rivaroxaban on Survival and Development of Complications of Portal Hypertension in Patients With Cirrhosis Recruiting NCT02643212 Phase 3
24 Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus Recruiting NCT02971345 Phase 3
25 Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism Recruiting NCT02585713 Phase 3
26 Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Weight Heparin in Child-Pugh B Cirrhotic Patients: a Randomized Controlled Study Recruiting NCT02271295 Phase 3
27 Combine TACE and RFA Versus TACE Alone for HCC With PVTT Recruiting NCT02301091 Phase 3
28 Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC Recruiting NCT02774187 Phase 3
29 HAIC Versus TACE for Advanced HCC Recruiting NCT02856126 Phase 3
30 Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation Recruiting NCT02889562 Phase 2, Phase 3
31 Haemorrhage Alleviation With Tranexamic Acid- Intestinal System Recruiting NCT01658124 Phase 3
32 Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein Active, not recruiting NCT01887717 Phase 3
33 Safety and Efficacy of Bemiparin in the Prevention of Thrombotic Events in Hospitalized Cirrhotic Patients Active, not recruiting NCT02802605 Phase 3
34 Role of (LMWH) in Prevention of Thromboembolic Complication After (TACE) in Hepatocellular Carcinoma. Not yet recruiting NCT02715492 Phase 3
35 Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer Withdrawn NCT00238160 Phase 3
36 Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC) Unknown status NCT02290977 Phase 2
37 A Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma Unknown status NCT01425996 Phase 1, Phase 2
38 Islet Transplantation Through an Indwelling Catheter in the Umbilical Vein Completed NCT02367534 Phase 1, Phase 2
39 Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma Completed NCT00910572 Phase 2
40 Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients Completed NCT00849264 Phase 2
41 Effectiveness and Safety of the Simultaneous Radiotherapy and Hyperthermia After Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Combined With Portal Vein Tumor Thrombosis Completed NCT01911000 Phase 2
42 Pneumatic Reversible Portal Vein Diameter Modulation After Major Hepatectomy Recruiting NCT02390713 Phase 1, Phase 2
43 Lipotecan Based Concurrent Chemoradiotherapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis Recruiting NCT03035006 Phase 1, Phase 2
44 Complement Inhibitor Eculizumab in Clinical Islet Transplantation Recruiting NCT02727608 Phase 2
45 P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma. Recruiting NCT01834963 Phase 2
46 Safety and Efficacy Study of Eglandin in Living Donor Liver Transplant Patient Recruiting NCT02350218 Phase 2
47 Allogeneic Islet Cells Transplanted Onto the Omentum Recruiting NCT02213003 Phase 1, Phase 2
48 Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli Recruiting NCT02333773 Phase 1, Phase 2
49 Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion Active, not recruiting NCT01850368 Phase 2
50 HR Combined With FOLFOX4 for HCC With PVTT Active, not recruiting NCT02452853 Phase 2

Search NIH Clinical Center for Portal Vein Thrombosis

Genetic Tests for Portal Vein Thrombosis

Genetic tests related to Portal Vein Thrombosis:

id Genetic test Affiliating Genes
1 Portal Vein Thrombosis 29

Anatomical Context for Portal Vein Thrombosis

MalaCards organs/tissues related to Portal Vein Thrombosis:

39
Liver, Colon, Myeloid, Spleen, Pancreas, Neutrophil, Whole Blood

Publications for Portal Vein Thrombosis

Articles related to Portal Vein Thrombosis:

(show top 50) (show all 676)
id Title Authors Year
1
Endovascular treatment of an unusual membranous obstruction of the inferior vena cava in Budd-Chiari syndrome complicated by mural portal vein thrombosis. ( 28483616 )
2017
2
Portal Vein Thrombosis in the Setting of Newly Diagnosed Cushing's Syndrome. ( 28491882 )
2017
3
Melioidosis with Portal Vein Thrombosis. ( 28473933 )
2017
4
The problem with incidental and chronic portal vein thrombosis. ( 28077255 )
2017
5
Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome. ( 28180235 )
2017
6
Management of portal vein thrombosis in cirrhosis: More shadows than lights. ( 27053401 )
2016
7
Necrotic Gastric Gangrene as Complication of Congestive Portal Venopathy from Portal Vein Thrombosis. ( 27622195 )
2016
8
Portal vein thrombosis in patients with cirrhosis: just a common finding or a predictor of poor outcome? ( 27740524 )
2016
9
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry. ( 27026379 )
2016
10
Management of portal vein thrombosis in cirrhosis: an update. ( 27075588 )
2016
11
Surgical alternatives in the treatment of portal vein thrombosis in liver transplantation: A case series. ( 27045611 )
2016
12
Role of Hyperhomocysteinemia and Methylene Tetrahydrofolate Reductase C677T Polymorphism in Idiopathic Portal Vein Thrombosis. ( 27051654 )
2016
13
Portal vein thrombosis after laparoscopic sleeve gastrectomy: presentation and management. ( 27178606 )
2016
14
Evaluation of the Value of d-Dimer, P-Selectin, and Platelet Count for Prediction of Portal Vein Thrombosis After Devascularization. ( 25633343 )
2016
15
Jack 2 negative essential thrombocytosis with portal vein thrombosis and portal cavernoma formation - A case report. ( 27728317 )
2016
16
Complication of portal vein thrombosis after right hemihepatectomy in a patient lacking the portal vein bifurcation. ( 27644579 )
2016
17
Toward a Comprehensive New Classification of Portal Vein Thrombosis inA Patients WithA Cirrhosis. ( 27575821 )
2016
18
Endovascular Reconstruction of Extrahepatic Portal Vein in Noncirrhotic and Nonmalignant Chronic Portal Vein Thrombosis Secondary to an Iatrogenic Stenotic Lesion. ( 27770082 )
2016
19
Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Technical Considerations. ( 26997089 )
2016
20
Extra-anatomical Meso-portal Venous Jump Graft Repair for Early Portal Vein Thrombosis After Liver Transplant in an Infant With a Hypoplastic Portal Vein: A Case Report. ( 27932178 )
2016
21
Characterization of Portal Vein Thrombosis (Neoplastic Versus Bland) on CT Images Using Software-Based Texture Analysis and Thrombus Density (Hounsfield Units). ( 27490095 )
2016
22
Portal vein thrombosis in patients with cirrhosis: underdiagnosis and undertreatment? ( 27216797 )
2016
23
Subtypes and clinical significance of common bile duct varices in portal vein thrombosis: diagnosis and follow-up by Doppler US and EUS. ( 27039318 )
2016
24
Techniques of TIPS in the treatment of liver cirrhosis combined with incompletely occlusive main portal vein thrombosis. ( 27620282 )
2016
25
Diffusion-Weighted MRI of Malignant versus Benign Portal Vein Thrombosis. ( 27390544 )
2016
26
Hyperhomocysteinemia and MTHFR C677T polymorphism in patients with portal vein thrombosis complicating liver cirrhosis. ( 27065203 )
2016
27
Left branch of portal vein thrombosis in a liver transplant recipient with donation after cardiac death donor: A case report. ( 27930543 )
2016
28
Screening and treatment of portal vein thrombosis in cirrhosis. ( 28081904 )
2016
29
Anticoagulation Therapy with Warfarin Versus Low-Dose Aspirin Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection. ( 27064832 )
2016
30
Lipoprotein(a) in patients with hepatocellular carcinoma and portal vein thrombosis. ( 27822883 )
2016
31
Possible Association Between the Methylenetetrahydrofolate Reductase Gene C677T Polymorphism and Preexisting Portal Vein Thrombosis in Liver Transplant Recipients. ( 27221722 )
2016
32
Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization. ( 27277261 )
2016
33
Portal Vein Thrombosis and Arterioportal Shunting Due To Chronic Cholangitis: A Rare Complication of Living-Donor Liver Transplant. ( 26790032 )
2016
34
Portal Vein Thrombosis and Arterioportal Fistula in Post Liver Transplant Recipient: A Case Report. ( 27790551 )
2016
35
Erratum to: Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry. ( 27662883 )
2016
36
Coagulation parameters in patients with cirrhosis and portal vein thrombosis treated sequentially with low molecular weight heparin and vitamin K antagonists. ( 27470055 )
2016
37
Thrombus Resolution in Two Patients with Portal Vein Thrombosis without Anticoagulation: Do We Need to Anticoagulate Patients with Portal Vein Thrombosis? ( 28031666 )
2016
38
Hydatid liver cyst causing portal vein thrombosis and cavernous transformation: a case report and literature review. ( 27895860 )
2016
39
Portal Vein Thrombosis After Splenic and Pancreatic Surgery. ( 27638624 )
2016
40
Efficacy of peritoneovenous shunt for treating tolvaptan-resistant refractory ascites in a cirrhotic patient with portal vein thrombosis: A case report. ( 27123091 )
2016
41
Interventional Treatment of Severe Portal Vein Thrombosis after Living-Donor Liver Transplantation. ( 27890896 )
2016
42
Hepatocellular adenoma with malignant transformation in a patient with neonatal portal vein thrombosis. ( 27042773 )
2016
43
Progression of Thrombus in Portal Vein, Superior Mesenteric Vein, and Splenic Vein Even on Anticoagulation in a Patient with Ascending Colonic Malignancy with Liver Metastasis: Portal Vein Thrombosis versus Portal Vein Tumor Thrombosis. ( 28031667 )
2016
44
Portal Vein Thrombosis in a Preterm Newborn with Mutation of the MTHFR and PAI-1 Genes and Sepsis by Candida parapsilosis. ( 27603544 )
2016
45
Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban. ( 27880998 )
2016
46
Hepatic Histology and Morphometric Measurements in Idiopathic Extrahepatic Portal Vein Thrombosis in Children, Correlated to Clinical Outcome of Meso-Rex Bypass. ( 28045719 )
2016
47
Portal vein thrombosis: The role of imaging in the clinical setting. ( 27965037 )
2016
48
Portal Vein Stent Placement in Five Patients with Chronic Portal Vein Thrombosis Prior to Pancreatic Surgery. ( 27287970 )
2016
49
Liver transplantation in a patient with complete portal vein thrombosis, is there a surgical way out? A case report. ( 27625785 )
2016
50
Portal vein thrombosis in liver cirrhosis - the added value of contrast enhanced ultrasonography. ( 27239658 )
2016

Variations for Portal Vein Thrombosis

Expression for Portal Vein Thrombosis

Search GEO for disease gene expression data for Portal Vein Thrombosis.

Pathways for Portal Vein Thrombosis

Pathways related to Portal Vein Thrombosis according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1
Show member pathways
12.64 APOH F2 F5 F7 JAK2 SELP
2
Show member pathways
12.39 F2 F5 F7 SERPINC1
3
Show member pathways
11.89 F2 F7 MTHFR SERPINE1
4
Show member pathways
11.76 F2 F5 F7 SERPINC1 SERPINE1
5 11.16 F2 F5 F7 SERPINC1 SERPINE1
6 11.08 AFP F2
7
Show member pathways
10.87 JAK2 SELP
8 10.5 F2 F7

GO Terms for Portal Vein Thrombosis

Cellular components related to Portal Vein Thrombosis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.7 AFP APOH F2 F5 F7 SERPINC1
2 endoplasmic reticulum lumen GO:0005788 9.35 AFP F2 F5 F7 SERPINC1
3 extracellular space GO:0005615 9.23 AFP APOH F2 F5 F7 SELP

Biological processes related to Portal Vein Thrombosis according to GeneCards Suite gene sharing:

(show all 15)
id Name GO ID Score Top Affiliating Genes
1 cellular protein metabolic process GO:0044267 9.73 AFP F2 F5 SERPINC1
2 ER to Golgi vesicle-mediated transport GO:0006888 9.72 F2 F5 F7
3 platelet degranulation GO:0002576 9.67 APOH F5 SELP SERPINE1
4 blood coagulation GO:0007596 9.65 F2 F5 F7 JAK2 SERPINC1
5 positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068 9.63 F2 JAK2 SELP
6 fibrinolysis GO:0042730 9.54 F2 SERPINE1
7 signal peptide processing GO:0006465 9.52 F2 F7
8 blood coagulation, intrinsic pathway GO:0007597 9.51 APOH F2
9 regulation of blood coagulation GO:0030193 9.5 APOH F2 SERPINC1
10 negative regulation of blood coagulation GO:0030195 9.49 APOH SERPINE1
11 peptidyl-glutamic acid carboxylation GO:0017187 9.48 F2 F7
12 response to vitamin K GO:0032571 9.4 F5 F7
13 negative regulation of fibrinolysis GO:0051918 9.33 APOH F2 SERPINE1
14 hemostasis GO:0007599 9.26 F2 F5 F7 SERPINC1
15 positive regulation of blood coagulation GO:0030194 8.92 APOH F2 F7 SERPINE1

Molecular functions related to Portal Vein Thrombosis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 serine-type endopeptidase activity GO:0004252 9.5 F2 F5 F7
2 receptor binding GO:0005102 9.46 F2 F7 JAK2 SERPINE1
3 lipopolysaccharide binding GO:0001530 9.26 F2 SELP
4 glycoprotein binding GO:0001948 9.13 APOH F7 SELP
5 heparin binding GO:0008201 8.92 APOH F2 SELP SERPINC1

Sources for Portal Vein Thrombosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....